- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07628231
Assessment of Sevoflurane Consumption During General Anesthesia With a Low Fresh Gas Flow Rate of 0.3 L/Min (FGF 03)
Driven by industry demands and the need for anesthesia that consumes fewer resources ("green anesthesia"), manufacturers of anesthesia ventilators have developed closed-circuit ventilators. In a closed-circuit system, during the exhalation phase, gases are not released outside the ventilator into the atmosphere but are injected into the inspiratory limb of the circuit after being warmed and having CO2 removed. It is a closed loop. However, the loop is not completely closed because a very small stream of air is additionally injected into the inspiratory limb to limit the risk of hypoxia. This small stream of air is called "Fresh Gas Flow" or FGF.
To optimize this closed-loop recirculation, manufacturers have designed machines capable of minimizing the fresh gas flow. In the 2000s, machines operated with FGFs of 2 L/min, dropping to flows as low as 0.5 L/min by 2010. This low-flow regime allows for an 80% reduction in halogenated gas (sevoflurane) consumption while maintaining the same efficiency. Recently, even more sophisticated machines have been designed with FGFs of 0.3 L/min. Some of these new machines will be commercially available on a large scale in 2026. As part of an industrial partnership, the Nîmes University Hospital has validated the post-CE marking of these machines for certain manufacturers (including General Electric); the post-CE marking allows the manufacturer to have access to usage data Given that this product has only recently been introduced to the market, very little data has been published on the use of sevoflurane in daily practice at very low FGF flow rates (0.3 to 0.5 L/min).
For the past four months, the Nîmes University Hospital has had two CE-marked machines (GE, CS 850) capable of ventilating at flow rates of 0.3 L/min. These machines are connected to software (Carestation Insight) that allows all anonymized ventilator data to be recorded independently of the users. This software has been in continuous use in 12 operating rooms since 2024 within our institution and has been the subject of numerous publications (see Ref. 19). All ventilation and sevoflurane data are continuously recorded and stored in a secure, anonymous cloud (Ref. 19).
The objective of this retrospective study is to analyze the database of sevoflurane consumption derived from the Carestation Insight software for patients who underwent general anesthesia with ventilation at FGF flow rates of 0.3 L/min and to compare these data with our database of patients under anesthesia at flow rates of 0.5 to 2 L/min, also derived from this same cloud.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: Philippe CUVILLON, PU-PH
- Telefonnummer: + 33 4.66.68.30.50
- E-post: philippe.cuvillon@chu-nimes.fr
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
Adult patients undergoing surgery under general anesthesia with mechanical ventilation
- Connected to a ventilator linked to the Carestaion software
- No refusal as indicated by a letter of consent
Exclusion Criteria:
- Refusal to participate
- Minor patients
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
FGF flow rates of 0.3
Patients who underwent general anesthesia with mechanical ventilation at a minute ventilation of 0.3
|
None, Pure observatinal study
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
sevoflurane consumption
Tidsramme: Perioperative
|
Measurement of sevoflurane consumption (in liters) per minute of anesthesia
|
Perioperative
|
|
FGF
Tidsramme: Perioperative
|
Measurement of gas flow rate (FGF) (L/minute).
|
Perioperative
|
Samarbeidspartnere og etterforskere
Etterforskere
- Studieleder: Anissa MEGZARI, Centre Hospitalier Universitaire de Nîmes
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- Local/2026/PC-01
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på None, Pure observatinal study
-
AstraZenecaFullførtBrystkreft | Onkologi | EpidemiologiAlgerie
-
Mayo ClinicHar ikke rekruttert ennåEndometriekarsinomForente stater
-
Jonsson Comprehensive Cancer CenterNational Institute on Aging (NIA)Har ikke rekruttert ennåKlinisk stadium III gastrisk kreft AJCC v8 | Klinisk stadium III Gastroøsofageal Junction Adenocarcinoma AJCC v8 | Klinisk stadium I Esophageal Adenocarcinoma AJCC v8 | Klinisk stadium I Esofagus plateepitelkarsinom AJCC v8 | Klinisk stadium I gastrisk kreft AJCC v8 | Klinisk stadium II Esophageal... og andre forholdForente stater
-
Mayo ClinicRekrutteringOndartet fast neoplasma | Neoplasma i hematopoetisk og lymfatisk systemForente stater
-
Mayo ClinicRekrutteringEndometriekarsinom | Prostata karsinomForente stater
-
Mayo ClinicRekrutteringOndartet fast neoplasma | Neoplasma i hematopoetisk og lymfatisk systemForente stater
-
University of Southern CaliforniaBristol-Myers Squibb; National Cancer Institute (NCI)RekrutteringIkke-småcellet lungekarsinomForente stater
-
City of Hope Medical CenterNational Cancer Institute (NCI)Har ikke rekruttert ennåOndartet fast neoplasma | Pode versus vertssykdom | Neoplasma i hematopoetisk og lymfatisk systemForente stater
-
City of Hope Medical CenterNational Cancer Institute (NCI)Rekruttering
-
Mayo ClinicHar ikke rekruttert ennåAkutt lymfatisk leukemi i barndommen | Lymfoblastisk lymfom i barndommenForente stater